| P50 | author | François Nosten | Q28033645 |
| | Laurent Rénia | Q29997936 |
| | Bruce Malcolm Russell | Q30347432 |
| P2093 | author name string | Mauricio M Rodrigues | |
| | Ricardo L D Machado | |
| | Irene S Soares | |
| | Fabio T M Costa | |
| | Kátia Sanches Françoso | |
| | Luciana Chagas Lima | |
| | Mariana Vilela Rocha | |
| | Tarsila Mendes Camargo | |
| P2860 | cites work | Safety and immunogenicity of a malaria vaccine, Plasmodium falciparum AMA-1/MSP-1 chimeric protein formulated in montanide ISA 720 in healthy adults | Q21144326 |
| | Merozoite surface proteins in red blood cell invasion, immunity and vaccines against malaria | Q26772878 |
| | Severe vivax malaria: a systematic review and meta-analysis of clinical studies since 1900 | Q26853034 |
| | Human ex vivo studies on asexual Plasmodium vivax: the best way forward | Q27026814 |
| | T cell epitope regions of the P. falciparum MSP1-33 critically influence immune responses and in vitro efficacy of MSP1-42 vaccines | Q28740432 |
| | Understanding the clinical spectrum of complicated Plasmodium vivax malaria: a systematic review on the contributions of the Brazilian literature | Q33399080 |
| | Plasmodium vivax malaria vaccines: why are we where we are? | Q34170071 |
| | Global extent of chloroquine-resistant Plasmodium vivax: a systematic review and meta-analysis | Q34259032 |
| | Global Population Structure of the Genes Encoding the Malaria Vaccine Candidate, Plasmodium vivax Apical Membrane Antigen 1 (PvAMA1). | Q35037036 |
| | Long-term humoral and cellular immune responses elicited by a heterologous Plasmodium vivax apical membrane antigen 1 protein prime/adenovirus boost immunization protocol | Q35191980 |
| | Synthetic double-stranded RNA induces innate immune responses similar to a live viral vaccine in humans | Q35669097 |
| | A reliable ex vivo invasion assay of human reticulocytes by Plasmodium vivax | Q36225497 |
| | Malaria vaccine-related benefits of a single protein comprising Plasmodium falciparum apical membrane antigen 1 domains I and II fused to a modified form of the 19-kilodalton C-terminal fragment of merozoite surface protein 1 | Q36313955 |
| | Apical membrane antigen 1: a malaria vaccine candidate in review | Q37069649 |
| | Seven-Year Efficacy of RTS,S/AS01 Malaria Vaccine among Young African Children | Q37130595 |
| | The carboxy-terminus of merozoite surface protein 1: structure, specific antibodies and immunity to malaria. | Q37559892 |
| | Invasion-inhibitory antibodies elicited by immunization with Plasmodium vivax apical membrane antigen-1 expressed in Pichia pastoris yeast | Q37643896 |
| | A Plasmodium vivax vaccine candidate displays limited allele polymorphism, which does not restrict recognition by antibodies. | Q41942680 |
| | Biophysical characterization of the recombinant merozoite surface protein-3 of Plasmodium vivax. | Q44394764 |
| | Fusion of two malaria vaccine candidate antigens enhances product yield, immunogenicity, and antibody-mediated inhibition of parasite growth in vitro | Q47644258 |
| | New malaria vaccine candidates based on the Plasmodium vivax Merozoite Surface Protein-1 and the TLR-5 agonist Salmonella Typhimurium FliC flagellin. | Q47878245 |
| | Comparison of the immunogenic properties of recombinant proteins representing the Plasmodium vivax vaccine candidate MSP1(19) expressed in distinct bacterial vectors | Q47893571 |
| | Immunogenic properties of the Plasmodium vivax vaccine candidate MSP1(19) expressed as a secreted non-glycosylated polypeptide from Pichia pastoris | Q47902024 |
| | A recombinant vaccine based on domain II of Plasmodium vivax Apical Membrane Antigen 1 induces high antibody titres in mice. | Q47948366 |
| | Immunogenicity of a recombinant protein containing the Plasmodium vivax vaccine candidate MSP1(19) and two human CD4+ T-cell epitopes administered to non-human primates (Callithrix jacchus jacchus). | Q48031671 |
| | Preclinical evaluation of a chimeric malaria vaccine candidate in Montanide ISA 720: immunogenicity and safety in rhesus macaques | Q48036373 |
| P433 | issue | 18 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Plasmodium vivax | Q311376 |
| P304 | page(s) | 2463-2472 | |
| P577 | publication date | 2017-03-21 | |
| P1433 | published in | Vaccine | Q7907941 |
| P1476 | title | Generation, characterization and immunogenicity of a novel chimeric recombinant protein based on Plasmodium vivax AMA-1 and MSP119. | |
| P478 | volume | 35 | |